U.S. Pharmaceutical Manufacturing Facilities Skyrocket in Value ahead of Tariffs
Key Takeaways Cambrex, a leading U.S. CDMO, valued at USD 4 Billion, nearly double its 2019 acquisition price. U.S. pharmaceutical…
Tue, Sep 16, 2025
USA Plant Setup News and Updates
Latest Updates on New Manufacturing Plants in USA and Compliance Regulations